Pharma companies are seeking to bolster pipelines and cut costs more than ever before in preparation for looming patent expirations of blockbuster drugs. In this environment global collaborations are increasing while budgets are shrinking, and as a result Internet-based communication has taken a prominent position in clinical development.

In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists. Join us for a live webcast as we discuss paperless clinical trials, covering the initiatives, the progress and what we have learned along the way.

Discussion will include:

The push for paperless: trends and initiatives
Clinical studies end-to-end: Which parts of the process are farthest along and which have the highest hurdles
Views on the benefits and burdens of transitioning to paperless for sites, sponsors, regulators and others
Where from here? Practical next steps towards the paperless trial.